NewsBytes
    Hindi Tamil Telugu
    More
    In the news
    Narendra Modi
    Amit Shah
    Box Office Collection
    Bharatiya Janata Party (BJP)
    OTT releases
    Hindi Tamil Telugu
    NewsBytes
    User Placeholder

    Hi,

    Logout

    India
    Business
    World
    Politics
    Sports
    Technology
    Entertainment
    Auto
    Lifestyle
    Inspirational
    Career
    Bengaluru
    Delhi
    Mumbai

    Download Android App

    Follow us on
    • Facebook
    • Twitter
    • Linkedin
    Home / News / India News / Now, Bharat Biotech seeks emergency use approval for COVAXIN
    Next Article
    Now, Bharat Biotech seeks emergency use approval for COVAXIN

    Now, Bharat Biotech seeks emergency use approval for COVAXIN

    By Shalini Ojha
    Dec 08, 2020
    12:14 pm

    What's the story

    After US-based Pfizer and Pune's Serum Institute of India, Bharat Biotech has sought an emergency use approval for its coronavirus vaccine, named COVAXIN.

    The vaccine is being developed indigenously by the Hyderabad-based company and the Indian Council of Medical Research (ICMR), the top government body leading the fight against coronavirus.

    The vaccine is currently in phase three trials.

    Here's more.

    Details

    Countries are giving approvals considering the unprecedented situation

    As per reports, an application regarding the same has been sent to the Drugs Controller General of India (DCGI). If granted permission, doses of the vaccine will be given to a select group of people.

    Such approvals are rare in nature, but countries have been going ahead with it considering the intensity of the pandemic.

    Till now, 1,550,263 have died worldwide.

    Quote

    Bharat Biotech submitted its application on Monday

    "This (Bharat Biotech's) is an application (under the category of) issue of permission to either import, manufacture a drug or for grant of clinical trial NOC (no-objection certificate)," a person privy to developments told Indian Express.

    Process

    Expert panel will review the submissions of three companies tomorrow

    As three companies have sought emergency use authorization, the government has also framed the next steps. As per reports, an expert panel will review their submissions tomorrow.

    After thoroughly assessing the requests, the panel will share its findings with DCGI, which will then take a call.

    The approval will only be granted once authorities are confident that the vaccine is safe and effective.

    Looking back

    Earlier, minister, who was given COVAXIN, tested positive for coronavirus

    Notably, last week, Haryana's minister Anil Vij, who was administered a dose of COVAXIN in November, tested positive for COVID-19.

    Later, officials conducting trials refused to link Vij's infection with the vaccine, saying he was only given the first of the two doses needed.

    They argued that antibodies to protect someone from the disease are generated after the second dose, reports Indian Express.

    India's tally

    Meanwhile, India's coronavirus tally is nearing the one crore mark

    Disturbingly, India is the second worst-hit nation and is inching close to the one crore mark, as far as infections are concerned.

    At 9,703,908 total cases, the country has lost 140,994 to the contagious disease. This means citizens are desperately waiting for a vaccine.

    Last week, Prime Minister Narendra Modi assured India won't have to wait for long.

    Facebook
    Whatsapp
    Twitter
    Linkedin
    Related News
    Latest
    Indian Council of Medical Research (ICMR)
    Coronavirus
    Serum Institute of India
    Bharat Biotech

    Latest

    Ruben Amorim dismisses Manchester United exit rumors: Details here Manchester United
    Tottenham's Kulusevski undergoes knee surgery ahead of Europa League final UEFA Europa League
    Rasmus Hojlund vs Dominic Solanke: Decoding their Europa League campaigns Rasmus Hojlund
    England's Archer, Curran and Overton won't feature in IPL remainder Jofra Archer

    Indian Council of Medical Research (ICMR)

    Modi orders drug regulatory system overhaul to reduce red tape Narendra Modi
    Centre slams Bengal over cross-border cargo, COVID-19 mortality rate West Bengal
    ICMR, Bharat Biotech teaming up to develop Indian COVID-19 vaccine Hindustan Times
    Why was India's discharge policy for COVID-19 patients changed? Union Health Ministry

    Coronavirus

    First doses of coronavirus vaccine for one crore healthcare workers Narendra Modi
    SpiceJet founders launch RT-PCR COVID-19 tests at just Rs. 499 SpiceJet
    Coronavirus: UK government extends work visas for Indian, foreign doctors United Kingdom
    India's smartphone exports may reach record $1.5B in 2020: Study Samsung

    Serum Institute of India

    India will start COVID-19 vaccine production next month: Details here Oxford
    COVID-19 vaccine: What are the latest updates? Oxford
    COVID-19 vaccine: What are the latest updates? Oxford
    India: Human trials of Oxford vaccine may start in August Oxford University

    Bharat Biotech

    India's first COVID-19 vaccine, COVAXIN, cleared for human trials Coronavirus
    India targets to launch first COVID-19 vaccine by August 15 Indian Council of Medical Research (ICMR)
    India's second COVID-19 vaccine cleared for human trials: Details here Drugs Controller General of India
    Following globally-accepted norms, says ICMR over August 15 vaccine target Vaccine
    Indian Premier League (IPL) Celebrity Hollywood Bollywood UEFA Champions League Tennis Football Smartphones Cryptocurrency Upcoming Movies Premier League Cricket News Latest automobiles Latest Cars Upcoming Cars Latest Bikes Upcoming Tablets
    About Us Privacy Policy Terms & Conditions Contact Us Ethical Conduct Grievance Redressal News News Archive Topics Archive Download DevBytes Find Cricket Statistics
    Follow us on
    Facebook Twitter Linkedin
    All rights reserved © NewsBytes 2025